Effects of infusion of L-arginine on exercise-induced myocardial ischemic ST-segment changes and capacity to exercise of patients with stable angina pectoris

Coronary Artery Disease

Volumn 10, Issue 5, 1999, Pages 321-326

  Kobayashi, Noboru ^a   Nakamura, Motoyuki ^a   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Angina pectoris; Endothelium; Exercise; L arginine; Nitric oxide

Indexed keywords

ADRENALIN; ARGININE; NITRIC OXIDE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG GAS EXCHANGE; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

EID: 0032767112     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199907000-00008     Document Type: Article

References (30)

1. 1 Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
2. 2 Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9269.
3. 3 Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-666.
4. 4 Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991 ; 88:1663-1671.
5. 5 Canty JM Jr, Schwartz JS. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation 1994; 89:375-384.
6. 6 Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81:491-497.
7. 7 Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990; 81:482-490.
8. 8 Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95:1747-1755.
9. 9 Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992; 85:1390-1397.
10. 10 Jones CJH, Kuo L, Davis MJ, DeFily DV, Chilian WM. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 1995; 91:1807-1813.
11. 11 Smith TP Jr, Canty JM Jr. Modulation of coronary autoregulatory responses by nitric oxide. Evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 1993; 73:232-240.
12. 12 Parent R, Pare R, Lavallee M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol 1992; 262:H10-H16.
13. 13 Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338:1546-1550.
14. 14 Dubois-Rande JL, Zelinsky R, Roudot F, Chabrier PE, Castaigne A, Geschwind H, et al. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol 1992; 70:1269-1275.
15. 15 Otsuji S, Nakajima O, Waku S, Kojima S, Hosokawa H, Kinoshita I, et al. Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis. Am Heart J 1995; 129:1094-1100.
16. 16 Ueshima K, Saito M, Shimohara A, Uchimoto S, Kawaguchi M, Fukami K, et al. Management and evaluation of non-supervised home exercise program in a convalescent phase of acute myocardial infarction. Jap Circ J 1990; 54:1437-1442.
17. 17 Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970; 2:92-98.
18. 18 Duncker DJ, Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary stenosis. Circ Res 1994; 74:629-640.
19. 19 Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96:3390-3395.
20. 20 Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension. Lancet 1990; 336:696.
21. 21 Bode-Boger SM, Boger RH, Creutzig A, Tsikas D, Gutzki FM, Alexander K, et al. L-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994; 87:303-310.
22. 22 Giugliano D, Marfella R, Verrazzo G, Acampora R, Nappo F, Ziccardi P, et al. L-Arginine for testing endothelium-dependent vascular functions in health and disease. Am J Physiol 1997; 273:E606-E612.
23. 23 Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 1992; 70:208-212
24. 24 Yamabe H, Okumura K, Ishizaka H, Tsuchiya T, Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Phyiol 1992; 263:H8-H14.
25. 25 Hirooka Y, Imaizumi T, Tagawa T, Shiramoto M, Endo T, Ando S, et al. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 1994; 90:658-668.
26. 26 Kanaya Y, Nakamura M, Kobayashi N, Hiramori K. Effects of L-arginine on lower limb vasodilatory reserve capacity and exercise parameters in patients with chronic heart failure. Heart 1999; 81:512-517.
27. 27 Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L, Cozzolino D, et al. The vascular effects of L-arginine in humans. The role of endogenous insulin. J Clin Invest 1997; 99:433-438.
28. 28 Wascher TC, Posch K, Wallner S, Hermetter A, Kostner GM, Graier WF. Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase? Biochem Biophys Res Commun 1997; 234:35-38.
29. 29 Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 1997; 80:331-333.
30. 30 Quyyumi AA. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double blind comparison of parenteral D-and L-arginine. J Am Coll Cardiol 1998; 32:904-911.